⌘K

Login Start Free

Home/Filings/4/0000875320-07-000019

4//SEC Filing

VERTEX PHARMACEUTICALS INC / MA 4

Accession 0000875320-07-000019

$VRTXCIK 0000875320operating

View on SEC.gov Company Profile

Filed

Jan 31, 7:00 PM ET

Accepted

Feb 1, 12:42 PM ET

Size

14.5 KB

Accession

0000875320-07-000019

Insider Transaction Report

Form 4

Period: 2007-01-31

VERTEX PHARMACEUTICALS INC / MAVRTX

SVP, Drug Eval. & Appr.

Transactions

Sale
Common Stock
2007-01-31$35.46/sh−1,000$35,460→ 135,960 total
Exercise/Conversion
Stock Options
2007-01-31−1,000→ 1,966 total
Exercise: $18.47Exp: 2007-09-25→ Common Stock (1,000 underlying)
Exercise/Conversion
Common Stock
2007-01-31$18.47/sh+1,000$18,470→ 136,460 total
Exercise/Conversion
Stock Options
2007-01-31−500→ 9,400 total
Exercise: $9.07From: 2004-03-11Exp: 2013-12-10→ Common Stock (500 underlying)
Exercise/Conversion
Common Stock
2007-01-31$9.07/sh+500$4,535→ 136,960 total
Sale
Common Stock
2007-01-31$35.46/sh−500$17,730→ 135,460 total

Holdings

Common Stock
(indirect: By 401(k))
6,265

Footnotes (3)

[F1]Transaction made pursuant to Dr. Alam's company approved trading plan established under rule 10b5-1.
[F2]Fully exercisable.
[F3]Right to buy under 1996 Stock and Option Plan, vesting quarterly over 4 years from 12/11/2003.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeoperating

IncorporatedMA

Related Parties

1

filerCIK 0000875320

Filing Metadata

Form type: 4
Filed: Jan 31, 7:00 PM ET
Accepted: Feb 1, 12:42 PM ET
Size: 14.5 KB

View on SEC.gov